Replies to post #298448 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

The FDA continues to encourage the development of abuse-deterrent formulations of opioids and believes that these products have promise to help reduce prescription drug abuse. At the same time, the FDA remains committed to ensuring that patients with pain have appropriate access to opioid analgesics.